April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Association Between Gene Expression Profile Classification and Thickness of Melanocytic Uveal Tumors Evaluated by FNAB
Author Affiliations & Notes
  • C. C. Simoes
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • Z. M. S. Corrêa
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • J. J. Augsburger
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • J. W. Harbour
    Ophthalmology, Washington University School of Medicine, St Louis, Missouri
  • Footnotes
    Commercial Relationships  C.C. Simoes, None; Z.M.S. Corrêa, None; J.J. Augsburger, None; J.W. Harbour, None.
  • Footnotes
    Support  NEI grant EY02687, NCI grant R01CA125970,Kling Family Foundation,Tumori Foundation,Barnes-Jewish Hosp Foundation& Horncrest Foundation,Research to Prevent Blindness,Quest for Vision Fund-U Cincinnati
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5762. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. C. Simoes, Z. M. S. Corrêa, J. J. Augsburger, J. W. Harbour; Association Between Gene Expression Profile Classification and Thickness of Melanocytic Uveal Tumors Evaluated by FNAB. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5762.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Gene expression profiling (GEP) of melanocytic uveal tumors had been shown to be the most accurate predictor of metastatic disease that has been reported to date. The purpose of this study was to determine whether there is any relationship between GEP classification and thickness of melanocytic uveal tumors sampled by fine needle aspiration biopsy (FNAB).

Methods: : Samples from 44 melanocytic uveal tumors were obtained by FNAB. Each sample was analyzed by GEP for the presence of the Class 1 (favorable) versus Class 2 (unfavorable) expression signature. The relationship between GEP classification and tumor thickness was evaluated by cross tabulation analysis and independent groups t testing.

Results: : Tumor thickness ranged from 1.8 to 12.0 mm (mean = 5.6 mm, std. dev. = 2.8 mm). The pre-FNAB clinical diagnosis was choroidal melanoma in 29 cases, ciliary body melanoma in 10, and choroidal nevus versus melanoma in 5. Sixteen tumors were ≤ 3.5 mm thick, 16 were between 3.5 and 7 mm thick, and 12 were > 7 mm thick. Twenty five tumors were categorized as Class 2 by GEP while 19 were categorized as Class 1. Four of the 16 tumors ≤ 3.5 mm thick (25%), 8 of 16 tumors between 3.5 and 7 mm thick (50%), and 7 of 12 tumors > 7 mm thick (58.3%) were Class 2. Mean thickness of the 25 Class 1 tumors was 4.6 mm (SD = 2.5 mm) while that of the 19 Class 2 tumors was 6.9 mm (SD = 2.7 mm). This difference is statistically significant (t test, P = 0.006).

Keywords: melanoma • gene/expression • oncology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×